MedPath

Research study of QOL with leukotriene receptor antagonist ,pranlukast in asthmatic patients by use of Asthma Health Questionnaire-Japan QOL (AHQ-JAPAN QOL)

Phase 4
Conditions
Asthma
Registration Number
JPRN-UMIN000000724
Lead Sponsor
Asthma QOL Research Study Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
1500
Inclusion Criteria

Not provided

Exclusion Criteria

Asthmatic patients with leukotoriene antagonists other than pranlukast.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
QOL Questionnaire of asthmatic patients by use of AHQ-JAPAN QOL and AQLQ.
Secondary Outcome Measures
NameTimeMethod
Pulmonary functions test((PEF,FVC and FEV)
© Copyright 2025. All Rights Reserved by MedPath